Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures.
about
Fatty Infiltration of Skeletal Muscle: Mechanisms and Comparisons with Bone Marrow AdiposityMechanisms of bone anabolism regulated by statinsDynamic expression of DKK1 protein in the process whereby Epimedium-derived flavonoids up-regulate osteogenic and down-regulate adipogenic differentiation of bone marrow stromal cells in ovariectomized ratsThe pathogenesis of nontraumatic osteonecrosis.Blood supply to the chicken femoral head.Preventive effects of puerarin on alcohol-induced osteonecrosis.Fullerol antagonizes dexamethasone-induced oxidative stress and adipogenesis while enhancing osteogenesis in a cloned bone marrow mesenchymal stem cell.Osteogenic response of human adipose-derived stem cells to BMP-6, VEGF, and combined VEGF plus BMP-6 in vitro.Locally applied Simvastatin improves fracture healing in mice.Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population?Effects of Na/K-ATPase and its ligands on bone marrow stromal cell differentiationBone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatmentStatins and osteoporosis: new role for old drugs.Propyl gallate inhibits adipogenesis by stimulating extracellular signal-related kinases in human adipose tissue-derived mesenchymal stem cells.Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic reviewStatin-induced calcification in human mesenchymal stem cells is cell death related.Statins and bone metabolism.From marrow oedema to osteonecrosis: common paths in the development of post-transplant bone pain.Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation.Lovastatin Reduces Stemness via Epigenetic Reprograming of BMP2 and GATA2 in Human Endometrium and Endometriosis.Osteogenic effects of D+beta-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats.Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia.Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis.Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation.Preventive effects of siRNA targeting PPARγ gene on steroid-induced osteonecrosis in rabbits.Salicylideneamino-2-thiophenol enhances osteogenic differentiation through the activation of MAPK pathways in multipotent bone marrow stem cell.Simvastatin induces osteogenic differentiation of murine embryonic stem cells.Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits.Integrin-adhesion ligand bond formation of preosteoblasts and stem cells in three-dimensional RGD presenting matricesStatin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation.The modulation of MSC integrin expression by RGD presentation.Effects of pyrite bioleaching solution of Acidithiobacillus ferrooxidans on viability, differentiation and mineralization potentials of rat osteoblasts.Role of MSX1 in Osteogenic Differentiation of Human Dental Pulp Stem Cells.Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats.Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression.Fast sequences MR imaging at the investigation of painful skeletal sites in patients with hip osteonecrosis.MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.Osteogenic activity of locally applied small molecule drugs in a rat femur defect model.Modulation of keratin in adhesion, proliferation, adipogenic, and osteogenic differentiation of porcine adipose-derived stem cells.Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study.
P2860
Q26744594-525DC196-C47D-4DA2-867A-DC2681177DCDQ26992028-93D3A730-4D2C-444A-9A57-56306E9D16B5Q28577701-4D7E1F07-6C24-43AF-A88F-F70C448D585DQ30423367-97A86DE7-C354-4126-B6DD-B57C7DEBAA5FQ30433323-812BB3EC-B40E-4990-90BF-591CF69C8B1CQ30439726-6653F58F-1BF0-46FC-AB1E-08F25BBD48B4Q30455468-3EACBCA0-97BB-44C2-8B8A-0C5C6D66ABB2Q30456161-0B69A57E-1CC7-43BD-84C1-A9D121ABF637Q33300481-0F36C808-292C-4DBA-9BB7-7AA9513D9060Q33570428-4D6EF044-E14B-419E-B7B1-78EF2D8DDE5AQ33875634-51B000DD-AE80-4602-9426-7301973066D0Q34038283-1EE34D7C-0030-4573-9D6C-9E001D623446Q34563901-45696F4F-44AC-42BF-99D5-06243C58E7FFQ35450793-9C41EBBE-B02E-4134-80D3-6189D8F78C1EQ35684790-251F08A2-401B-44B4-B4B7-8695386AFE44Q35889100-FE0AE37B-51DC-4021-825C-CD433C2D54CFQ36395695-144BF011-9673-4458-9AFD-F7CC61E8DA96Q36697776-77E1A9B0-9BA8-47BE-A487-5DE5CED5116EQ37414061-933B469C-BECA-4DB4-9F44-BA783C80516AQ37590926-52AE88A4-BCA6-4047-92A7-6434986C8301Q37728138-103103E9-3642-405A-BC54-A124FA86D890Q37955195-F63EE108-8E1C-483B-ADCB-98C7635D7823Q38102644-5637DF0C-8AFD-4EA3-A3B3-C34E31424CD9Q38177814-65D1E2E4-83FF-4363-B583-0B9B890BA073Q38305955-D98CE249-15C7-4367-BE48-821D255AC700Q39415421-D89B7591-C524-44B8-BD91-2312094C0F39Q39861887-D54CAD89-6F47-483A-BE49-1D0D217040C1Q39887300-E4FEB5B3-4863-4966-B79D-BC4DFF255A18Q40000646-8A636764-1258-4CF5-9420-A4AF15079890Q40192599-8448731D-74A5-40D6-B0DB-6FAF1AB6654CQ40613631-7DF886FD-717D-4DD7-A4DF-0ECE00DF41D0Q40632135-50675ED1-BE8E-4320-A4E2-04C556F306C5Q41060685-9C692296-00EE-43A2-9DCF-03FC2575B37BQ41084727-1C6CBCA2-240A-47AF-B165-0039D08C48C3Q41591074-F76AAD41-2465-4B69-9C75-A5BDB7B80710Q41822631-5945227D-9859-4F4F-9974-FCA5EE5A6561Q42657433-0C343E22-7899-4656-BB36-C2C6E7919E35Q42738621-6C6AAB19-8B11-4405-BFAA-B6C3FF364D95Q42819864-89FDC4FB-148C-4EA6-BE90-695D8CD1560EQ43135937-BA7FCC8D-FEFC-4683-B7B2-FBCDC5FE54C6
P2860
Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lovastatin inhibits adipogenic ...... row mesenchymal cell cultures.
@ast
Lovastatin inhibits adipogenic ...... row mesenchymal cell cultures.
@en
type
label
Lovastatin inhibits adipogenic ...... row mesenchymal cell cultures.
@ast
Lovastatin inhibits adipogenic ...... row mesenchymal cell cultures.
@en
prefLabel
Lovastatin inhibits adipogenic ...... row mesenchymal cell cultures.
@ast
Lovastatin inhibits adipogenic ...... row mesenchymal cell cultures.
@en
P2093
P1433
P1476
Lovastatin inhibits adipogenic ...... row mesenchymal cell cultures.
@en
P2093
Chinghai Kao
Gary Balian
Gwo Jaw Wang
Quanjun Cui
P304
P356
10.1016/S8756-3282(03)00239-4
P577
2003-10-01T00:00:00Z